Using Dendritic Cells to Create Cancer Vaccines

November 13, 2007 presentation by Edgar Engleman for the Stanford School of Medicine Medcast lecture series. Edgar Engleman, MD, medical director of the Stanford Blood Center, discusses his research involving the use of a special type of white blood cell as a treatment for cancer. Engleman, who is also a professor of pathology at the Stanford School of Medicine, and his team of researchers have been interested in dendritic cells, or DCs, which can provoke an immune response in the body. Stanford University School of Medicine: med.stanford.edu Stanford University Channel on YouTube: www.youtube.com
Video Rating: 4 / 5